These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 10921330)

  • 21. The molecular basis of xeroderma pigmentosum.
    Copeland NE; Hanke CW; Michalak JA
    Dermatol Surg; 1997 Jun; 23(6):447-55. PubMed ID: 9217796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shining a light on xeroderma pigmentosum.
    DiGiovanna JJ; Kraemer KH
    J Invest Dermatol; 2012 Mar; 132(3 Pt 2):785-96. PubMed ID: 22217736
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro: a model to study hypersensitivity to UV light.
    Bernerd F; Asselineau D; Frechet M; Sarasin A; Magnaldo T
    Photochem Photobiol; 2005; 81(1):19-24. PubMed ID: 15369409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of a human DNA excision repair gene involved in group A xeroderma pigmentosum and containing a zinc-finger domain.
    Tanaka K; Miura N; Satokata I; Miyamoto I; Yoshida MC; Satoh Y; Kondo S; Yasui A; Okayama H; Okada Y
    Nature; 1990 Nov; 348(6296):73-6. PubMed ID: 2234061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mouse model for the DNA repair/basal transcription disorder trichothiodystrophy reveals cancer predisposition.
    de Boer J; van Steeg H; Berg RJ; Garssen J; de Wit J; van Oostrum CT; Beems RB; van der Horst GT; van Kreijl CF; de Gruijl FR; Bootsma D; Hoeijmakers JH; Weeda G
    Cancer Res; 1999 Jul; 59(14):3489-94. PubMed ID: 10416615
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53 mutations in skin and internal tumors of xeroderma pigmentosum patients belonging to the complementation group C.
    Giglia G; Dumaz N; Drougard C; Avril MF; Daya-Grosjean L; Sarasin A
    Cancer Res; 1998 Oct; 58(19):4402-9. PubMed ID: 9766670
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
    Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
    Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
    Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
    Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
    Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
    Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Xeroderma pigmentosum patients belonging to complementation group F and efficient liquid-holding recovery of ultraviolet damage.
    Nishigori C; Fujisawa H; Uyeno K; Kawaguchi T; Takebe H
    Photodermatol Photoimmunol Photomed; 1991 Aug; 8(4):146-50. PubMed ID: 1814424
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rare exon 10 deletion in POLH gene in a family with xeroderma pigmentosum variant correlating with protein expression by immunohistochemistry.
    Borroni RG; Diegoli M; Grasso M; Concardi M; Agozzino M; Vignini M; Arbustini E
    G Ital Dermatol Venereol; 2020 Jun; 155(3):349-354. PubMed ID: 32635709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
    Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
    Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sunlight, Vitamin D, and Xeroderma Pigmentosum.
    Martens MC; Emmert S; Boeckmann L
    Adv Exp Med Biol; 2020; 1268():319-331. PubMed ID: 32918226
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Yeast RAD14 and human xeroderma pigmentosum group A DNA-repair genes encode homologous proteins.
    Bankmann M; Prakash L; Prakash S
    Nature; 1992 Feb; 355(6360):555-8. PubMed ID: 1741034
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated oncogenes in human skin tumors from a repair-deficient syndrome, xeroderma pigmentosum.
    Suarez HG; Daya-Grosjean L; Schlaifer D; Nardeux P; Renault G; Bos JL; Sarasin A
    Cancer Res; 1989 Mar; 49(5):1223-8. PubMed ID: 2645047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of effective skin cancer treatment and prevention in xeroderma pigmentosum.
    Lambert WC; Lambert MW
    Photochem Photobiol; 2015; 91(2):475-83. PubMed ID: 25382223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Requirement for functional DNA polymerase eta in genome-wide repair of UV-induced DNA damage during S phase.
    Auclair Y; Rouget R; Belisle JM; Costantino S; Drobetsky EA
    DNA Repair (Amst); 2010 Jul; 9(7):754-64. PubMed ID: 20457011
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Xeroderma pigmentosa: three new cases with an in depth review of the genetic and clinical characteristics of the disease.
    Karass M; Naguib MM; Elawabdeh N; Cundiff CA; Thomason J; Steelman CK; Cone R; Schwenkter A; Jordan C; Shehata BM
    Fetal Pediatr Pathol; 2015 Apr; 34(2):120-7. PubMed ID: 25454817
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Xeroderma pigmentosum. A study in 40 Algerian patients].
    Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
    Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Exploring DNA damage responses in human cells with recombinant adenoviral vectors.
    Armelini MG; Lima-Bessa KM; Marchetto MC; Muotri AR; Chiganças V; Leite RA; Carvalho H; Menck CF
    Hum Exp Toxicol; 2007 Nov; 26(11):899-906. PubMed ID: 18042584
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.